IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today reported that an overview of the Company’s business strategy will be given at the Robert W. Baird & Co., Inc. 2010 Healthcare Conference, being held at the St. Regis Hotel in New York City. The Spectrum Pharmaceuticals presentation is at 10:00 a.m. Eastern Time on Wednesday, September 15, 2010 in the Versailles Ballroom on the 2nd Floor.
